Ascendis Health Limited

    Ascendis Health Limited

    JJSE:ASC
    92.00
    ZAc
    0.00
    (0.00%)
    Ascendis Health Limited
    JSE:ASC
    (Johannesburg Stock Exchange)

    Recent

    price

    92.00

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    ZAR
    2.55
    7.43
    10.42
    13.92
    15.35
    11.78
    12.15
    4.56
    3.74
    3.25
    - -
    Revenue per Share
    0.04
    0.63
    0.78
    0.56
    0.68
    0.55
    -9.74
    -2
    -2.24
    0.94
    - -
    Basic EPS, GAAP
    -0.26
    0.39
    0.02
    -2.44
    0.37
    0.91
    -0.48
    0.37
    1.25
    -0.31
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    0.23
    0.2
    0.27
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    1.69
    5.79
    6.94
    9.01
    14.19
    14.52
    4.24
    2.17
    -0.24
    0.84
    - -
    Book Value per Share
    0.29
    -0.74
    -0.87
    -2.08
    -9.29
    -6.54
    -6.73
    -8.8
    0.31
    0.6
    - -
    Tangible Book Value per Share
    234
    218
    270
    281
    417
    468
    483
    483
    487
    480
    - -
    Basic Weighted Avg Shares
    597
    1,618
    2,817
    3,914
    6,409
    5,511
    5,872
    2,203
    1,825
    1,559
    1,535
    Sales/Revenue/Turnover
    7.34
    9.92
    11.92
    7.62
    10.52
    8.26
    5.13
    -9.63
    -24.3
    -11.95
    -12.86
    Operating Margin (%)
    9
    33
    60
    84
    210
    261
    248
    144
    85
    80
    76
    Depreciation Expense
    9
    136
    210
    159
    283
    257
    -4,710
    -966
    -1,091
    449
    75
    Net Income, GAAP
    77.6
    24.65
    28.22
    26.52
    14.63
    54.21
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    1.59
    8.42
    7.45
    4.06
    4.42
    4.67
    -80.22
    -43.84
    -59.75
    28.8
    4.91
    Profit Margin (%)
    79
    242
    541
    523
    1,108
    1,591
    -3,703
    2,143
    -40
    70
    367
    Working Capital
    84
    415
    798
    1,052
    4,023
    4,582
    227
    6,579
    174
    162
    19
    LT Debt
    388
    1,211
    1,824
    2,455
    5,296
    6,774
    2,080
    1,421
    514
    402
    563
    Total Equity
    - -
    8.91
    10.28
    6.44
    7.93
    1.83
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    12.76
    11.58
    6.06
    6.67
    3.27
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    16.46
    13.38
    7.2
    6.69
    4.05
    -106.6
    -62.33
    - -
    - -
    15.34
    Return on Common Equity (%)

    Capital Structure

    ZAR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    ZAR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    ZAR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    29.42%
    -29.31%
    40.09%
    Free Cash Flow
    -1,522.45%
    -39.92%
    17.97%
    Net Income, GAAP
    -78.59%
    -444.33%
    -83.23%
    Sales/Revenue/Turnover
    24.44%
    -17.84%
    -1.54%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    ZAR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    1,825
    2022
    - -
    - -
    - -
    - -
    1,559
    2023
    - -
    - -
    - -
    - -
    1,535

    Quarterly Earnings Per Share

    ZAR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    -2.24
    2022
    - -
    - -
    - -
    - -
    0.94
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    ZAR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business